Endocrine profiles after radiotherapy in stage I seminoma: Impact of two different radiation treatment modalities

被引:35
作者
Joos, H
Sedlmayer, F
Gomahr, A
Rahim, HBK
Frick, J
Kogelnik, HD
Rettenbacher, L
机构
[1] LANDESKRANKENANSTALTEN SALZBURG,INST RADIOTHERAPY & RADIOONCOL,A-5020 SALZBURG,AUSTRIA
[2] LANDESKRANKENANSTALTEN SALZBURG,INST ENDOCRINOL & NUCL MED,A-5020 SALZBURG,AUSTRIA
关键词
seminoma; radiotherapy; scatter dose; endocrinology; follicle stimulating hormone; luteinizing hormone;
D O I
10.1016/S0167-8140(97)00052-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: In patients with stage I seminoma treated with elective lymph node irradiation, testicular scatter doses are often thought to be responsible for later disturbances in fertility. We studied the influence of radiation field extensions and testicular doses on hormonal function. Materials and methods: FSH (follicle stimulating hormone) and LH (luteinizing hormone) were evaluated before radiotherapy (RT) and by serial analyses after treatment for 4 years. Twenty-three patients were irradiated by hockey stick fields with a mean dose of 31.9 Gy (+/-4.7 SD) and a mean scatter dose of 54 8 cGy (+/-16.6 SD). Twenty-one patients received limited RT to the paraaortic nodes with 28.1 Gy (+/-2.4 SD). The mean testicular dose was only 25 cGy (+/-7.8 SD). All patients had normal pre-treatment hormonal values. Results: Six months after the end of RT, mean FSH values were significantly elevated in the hockey stick group (P = 0.032), returning to normal after 3 years. The increase in LH was also significant, but stayed within normal ranges. Limited RT resulted in a minimal, dose-dependent increase of FSH; no changes in LH were noted. Conclusions: In patients with a normal hormonal status after semicastration, FSH is a reliable monitor for transient radiation-induced effects. To avoid treatment-related disturbances in spermatogenesis, scatter doses should be reduced to less than 20 cGy. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 27 条
[1]  
BALL D, 1982, CANCER, V50, P2289, DOI 10.1002/1097-0142(19821201)50:11<2289::AID-CNCR2820501112>3.0.CO
[2]  
2-X
[3]  
BERTHELSEN JG, 1984, FERTIL STERIL, V41, P281
[4]   EVIDENCE FOR DECREASING QUALITY OF SEMEN DURING PAST 50 YEARS [J].
CARLSEN, E ;
GIWERCMAN, A ;
KEIDING, N ;
SKAKKEBAEK, NE .
BRITISH MEDICAL JOURNAL, 1992, 305 (6854) :609-613
[5]   RADIOTHERAPY FOR TESTICULAR SEMINOMA STAGE-I - TREATMENT RESULTS AND LONG-TERM POST-IRRADIATION MORBIDITY IN 365 PATIENTS [J].
FOSSA, SD ;
AASS, N ;
KAALHUS, O .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (02) :383-388
[6]   PRETREATMENT DNA-PLOIDY OF SPERM CELLS AS A PREDICTIVE PARAMETER OF POSTTREATMENT SPERMATOGENESIS IN PATIENTS WITH TESTICULAR CANCER [J].
FOSSA, SD ;
SILDE, J ;
THEODORSEN, L ;
PETTERSEN, EO .
BRITISH JOURNAL OF UROLOGY, 1994, 74 (03) :359-365
[7]   POSTTREATMENT FERTILITY IN PATIENTS WITH TESTICULAR CANCER .3. INFLUENCE OF RADIOTHERAPY IN SEMINOMA PATIENTS [J].
FOSSA, SD ;
ABYHOLM, T ;
NORMANN, N ;
JETNE, V .
BRITISH JOURNAL OF UROLOGY, 1986, 58 (03) :315-319
[8]  
FOSSA SD, 1996, IN PRESS P ANN M AM, P595
[9]  
GREINER R, 1982, STRAHLENTHER ONKOL, V158, P342
[10]  
GRIFFIN J E, 1985, P259